Notícias

Abstract

COVID-19, caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a global pandemic and...

Abstract

It is an urgent demand worldwide to control the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute...

Summary

Background

Limited data exists regarding the efficacy of ChAdOx1-nCoV-19 vaccine against Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in...

Data: 16/08/2022

O mercado mostra-se promissor, porém não é uma área muito buscada entre os jovens por falta de incentivo do setor,...

Summary

Background

Little is known about vaccine effectiveness over time among adolescents, especially against the SARS-CoV-2 omicron (B.1.1.529) variant. This...

Abstract

The spread of coronavirus diseases has resulted in a clarion call to develop potent drugs and vaccines even as...

Summary

Neutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,...

O InnoPharma Conference tem como missão ser o principal Encontro Regional de Fornecedores da Indústria Farmacêutica, reunir em um mesmo lugar toda...

Abstract

The unprecedented outbreak of the severe acute respiratory syndrome (SARS) Coronavirus-2, across the globe, triggered a worldwide uproar in...

Lara Alzyoud,1 Mohammad A Ghattas,1,2 Noor Atatreh1,2

A ABIFINA alcançou 4 mil patentes incluídas em suas bases de dados de Monitoramento de Pedidos de Patentes (MPPs). Esses...